Glycopyrronium + Indacaterol + Mometasone

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandComposition & strengthManufacturer
ENERZAIR BREEZHALERAU CA ES EU MX
  • powder ×3 Glycopyrronium + Indacaterol + Mometasone
  • inhalation ×2 Glycopyrronium 0.046 mg + Indacaterol 0.114 mg + Mometasone 0.136 mg
  • inhalation Glycopyrronium 0.046 mg + Indacaterol 0.114 mg + Mometasone 0.068 mg
  • capsule Glycopyrronium 0.05 mg + Indacaterol 0.15 mg + Mometasone 0.16 mg
Novartis Europharm Limited
indacaterol + glycopyrronium + mometasoneAU ES0.114 mg / 0.046 mg / 0.136 mg / 0.068 mgNovartis Europharm Limited
ZIMBUS BREEZHALERAU ES EU
  • unknown ×2 Glycopyrronium + Indacaterol + Mometasone
  • inhalation Glycopyrronium 0.046 mg + Indacaterol 0.114 mg + Mometasone 0.136 mg
Novartis Europharm Limited
indacaterol + glicopirronio + mometasonaES0.114 mg / 0.046 mg / 0.136 mgNovartis Europharm Limited
ENERZAIR BREEZHALER INHALATION POWDER, HARD CAPSULE 150 MCG /50 MCG /160 MCGHK SG
  • unknown Glycopyrronium + Indacaterol + Mometasone
  • powder Glycopyrronium 0.05 mg + Indacaterol 0.15 mg + Mometasone 0.16 mg
NOVARTIS (SINGAPORE) PTE LTD
Enerzair Breezhaler 114micrograms/dose / 46micrograms/dose / 136micrograms/dose inhalation powder capsules with deviceGB
  • capsule Glycopyrronium + Indacaterol + Mometasone
Novartis Pharmaceuticals UK Ltd
Generic Enerzair Breezhaler 114micrograms/dose / 46micrograms/dose / 136micrograms/dose inhalation powder capsules with deviceGB—Novartis Pharmaceuticals UK Ltd
mometasone furoate + indacaterol acetate + glycopyrronium bromideAU——
indacaterol acetate + glycopyrronium bromide + mometasone furoateAU——
ENERZAIR BREEZHALER 114/46/136 indacaterol/glycopyrronium/mometasone furoate 114/46/136 microgram powder for inhalation in capsule with inhalerAU
  • capsule Glycopyrronium 0.063 mg + Indacaterol 0.173 mg + Mometasone 0.16 mg
Novartis Pharmaceuticals Australia Pty Ltd
ENERZAIR BREEZHALER 114/46/68 indacaterol/glycopyrronium/mometasone furoate 114/46/68 microgram powder for inhalation in capsule with inhalerAU
  • capsule Glycopyrronium 0.063 mg + Indacaterol 0.173 mg + Mometasone 0.08 mg
Novartis Pharmaceuticals Australia Pty Ltd
ZIMBUS BREEZHALER 114/46/68 indacaterol/glycopyrronium/mometasone furoate 114/46/68 microgram powder for inhalation in capsule with inhalerAU
  • capsule Glycopyrronium 0.063 mg + Indacaterol 0.173 mg + Mometasone 0.08 mg
Grand Medical Pty Ltd
ZIMBUS BREEZHALER 114/46/136 indacaterol/glycopyrronium/mometasone furoate 114/46/136 microgram powder for inhalation in capsule with inhalerAU
  • capsule Glycopyrronium 0.063 mg + Indacaterol 0.173 mg + Mometasone 0.16 mg
Grand Medical Pty Ltd
ENERZAIR BREEZHALER 114 microgrammes/46 microgrammes/136 microgrammes, poudre pour inhalation en géluleFR
  • capsule Glycopyrronium 0.063 mg + Indacaterol + Mometasone 0.16 mg
NOVARTIS EUROPHARM (IRLANDE)
エナジア吸入用カプセル中用量JP
  • capsule Glycopyrronium + Indacaterol + Mometasone
ノバルティス ファーマ
エナジア吸入用カプセル高用量JP
  • capsule Glycopyrronium + Indacaterol + Mometasone
ノバルティス ファーマ

Same combination in other markets

These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.